KAN-101-02 Coeliac Disease Study

We are looking for people who are interested in helping develop new treatments for coeliac disease in New Zealand! Sign up to our research community to be notified about upcoming research and opportunities to get involved.

Contents

Join Our Research Community

If you qualify, please use the link below to sign up for our Coeliac Research Community.

Requirements At a Glance

What Is The KAN-101–02 Study?

Coeliac disease is a digestive and autoimmune disorder that affects your small intestine, which can be triggered by gluten. KAN-101 is an investigational Coeliac Disease treatment, which acts by teaching immune cells to become tolerant toward gluten. 

What Is Clinical Research?

Clinical research is the process of developing potential treatments for diseases. Medicines must pass through clinical trials to ensure their safety and effectiveness.

Trial Information

Do You Qualify For The Trial?

What You Need To Know

What To Expect From Us

Help Find A Coeliac Disease Treatment

Volunteer For The KAN-101 Coeliac Disease Study. We are actively looking for people who are interested in helping develop new treatments for coeliac disease in New Zealand. If you qualify, please sign up for our Coeliac Research Community.

Sign Up To Your Closest Study Site